Compounds > n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and bimatoprost

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with bimatoprost in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Studies
(bimatoprost)		Trials
(bimatoprost)		Recent Studies (post-2010) (bimatoprost)
214558594184269

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, KJ; Hsieh, CM; Liou, JP; Nepali, K1

Reviews

1 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and bimatoprost

ArticleYear
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Administration, Ophthalmic; Drug Delivery Systems; Drug Design; Eye Diseases; Genetic Therapy; Humans; Regeneration; Structure-Activity Relationship

2020